SPOTLIGHT: Drugmakers lobby for preferred reforms

So, it's spring in Washington, DC, and what are the pharmas up to under the cherry blossoms? Not surprisingly, industry leaders are lobbying hard to shape the administration's pending healthcare reform plans. Among other things, they're hoping to keep provisions in place that would push billions into their pockets from newly-insured patients. FiercePharma [1]